Lab News
Lab tests show vitamin D, omega-3 fish oil miss health markers
November 12, 2019 -- Supplementation with vitamin D and omega-3 fatty acids failed to improve standard lab markers for inflammation and kidney function in two ancillary studies of the landmark Vitamin D and Omega-3 Trial (VITAL) that were reported in early November. The results reinforce a cautionary stance on supplementation and testing.
Discuss
November 12, 2019 -- Supplementation with vitamin D and omega-3 fatty acids failed to improve standard lab markers for inflammation and kidney function in two ancillary studies of the landmark Vitamin D and Omega-3 Trial (VITAL) that were reported in early November. The results reinforce a cautionary stance on supplementation and testing.
Discuss AMP highlights: Products aim to beat the clock in cancer detection
November 11, 2019 -- Cancer was a key focus at the recent Association for Molecular Pathology (AMP) annual meeting in Baltimore -- particularly faster detection and treatment selection, according to Bruce Carlson, publisher of Kalorama Information.
Discuss
November 11, 2019 -- Cancer was a key focus at the recent Association for Molecular Pathology (AMP) annual meeting in Baltimore -- particularly faster detection and treatment selection, according to Bruce Carlson, publisher of Kalorama Information.
Discuss CDC finds vitamin E acetate in 100% of vaping cases
November 8, 2019 -- In news that sheds light on the recent outbreak of vaping-related lung disease, the U.S. Centers for Disease Control and Prevention (CDC) on November 8 disclosed that the presence of vitamin E acetate was discovered in 100% of lung fluid samples from 29 patients that were submitted to the agency from 10 states.
Discuss
November 8, 2019 -- In news that sheds light on the recent outbreak of vaping-related lung disease, the U.S. Centers for Disease Control and Prevention (CDC) on November 8 disclosed that the presence of vitamin E acetate was discovered in 100% of lung fluid samples from 29 patients that were submitted to the agency from 10 states.
Discuss What will it take for home cervical cancer testing to take off?
November 8, 2019 -- Self-sampling by women for cervical cancer screening promises to be highly effective clinically, though practical hurdles remain in terms of implementation on a large scale, according to new studies reported this week.
Discuss
November 8, 2019 -- Self-sampling by women for cervical cancer screening promises to be highly effective clinically, though practical hurdles remain in terms of implementation on a large scale, according to new studies reported this week.
Discuss AMP roundup: Vendors showcase same-day NGS, faster prep, DNA/RNA combos
November 7, 2019 -- BALTIMORE - Bruce Carlson, publisher of Kalorama Information, is on the ground at the Baltimore Convention Center for this week's Association for Molecular Pathology (AMP) meeting, reporting on product introductions.
Discuss
November 7, 2019 -- BALTIMORE - Bruce Carlson, publisher of Kalorama Information, is on the ground at the Baltimore Convention Center for this week's Association for Molecular Pathology (AMP) meeting, reporting on product introductions.
Discuss AMP lineup shows changing of the guard in molecular tech
November 6, 2019 -- Bruce Carlson, publisher of Kalorama Information, shares his thoughts on the many vendor workshops slated for the upcoming Association for Molecular Pathology (AMP) annual meeting in Baltimore.
Discuss
November 6, 2019 -- Bruce Carlson, publisher of Kalorama Information, shares his thoughts on the many vendor workshops slated for the upcoming Association for Molecular Pathology (AMP) annual meeting in Baltimore.
Discuss FDA flags persistent problems with biotin interference
November 5, 2019 -- The U.S. Food and Drug Administration (FDA) on November 5 issued a warning regarding lab tests that have not yet been addressed for biotin interference. The communiqué instructs lab personnel to communicate more with patients and health providers to help avoid false reporting.
Discuss
November 5, 2019 -- The U.S. Food and Drug Administration (FDA) on November 5 issued a warning regarding lab tests that have not yet been addressed for biotin interference. The communiqué instructs lab personnel to communicate more with patients and health providers to help avoid false reporting.
Discuss ACP advises biennial -- not annual -- stool tests for colon cancer
November 5, 2019 -- In a debatable move, the American College of Physicians (ACP) advised biennial -- rather than annual -- testing of stool for signs of colorectal cancer in average-risk individuals in a clinical guideline published November 5 in the Annals of Internal Medicine. Furthermore, stool DNA testing did not make the cut.
Discuss
November 5, 2019 -- In a debatable move, the American College of Physicians (ACP) advised biennial -- rather than annual -- testing of stool for signs of colorectal cancer in average-risk individuals in a clinical guideline published November 5 in the Annals of Internal Medicine. Furthermore, stool DNA testing did not make the cut.
Discuss CA-125 blood test better than expected in ovarian cancer
November 5, 2019 -- The performance of the cancer antigen 125 (CA-125) blood test for detecting ovarian cancer surpassed expectations in a study of more than 50,000 symptomatic women seen in primary care, researchers reported on November 5 at the U.K. National Cancer Research Institute meeting in Glasgow.
Discuss
November 5, 2019 -- The performance of the cancer antigen 125 (CA-125) blood test for detecting ovarian cancer surpassed expectations in a study of more than 50,000 symptomatic women seen in primary care, researchers reported on November 5 at the U.K. National Cancer Research Institute meeting in Glasgow.
Discuss Cancer patients starved for information on genomic test costs
November 4, 2019 -- Oncologists have a lot of room for improvement when it comes to discussing the costs associated with genomic testing with their patients, according to a survey published on November 1 in the Journal of the National Cancer Institute.
Discuss
November 4, 2019 -- Oncologists have a lot of room for improvement when it comes to discussing the costs associated with genomic testing with their patients, according to a survey published on November 1 in the Journal of the National Cancer Institute.
Discuss
News in Brief
Conferences
Practical and Effective Diagnostic Hematopathology
November 11-14
San Diego, California United States
November 11-14
San Diego, California United States
Personalized Medicine Conference
November 13-14
Boston, Massachusetts United States
November 13-14
Boston, Massachusetts United States
American Society for Clinical Pathology (ASCP) Workshops for Laboratory Professionals
November 13-15
Minneapolis, Minnesota United States
November 13-15
Minneapolis, Minnesota United States
In Vitro Diagnostic Regulation (IVDR) CE Marking Workshop
November 21
London, London, City of United Kingdom
November 21
London, London, City of United Kingdom
Oncologic Pathology: A Review and Update of Diagnostic Problems
November 21-23
Miami, Florida United States
November 21-23
Miami, Florida United States
Connect
Latest Tweets